X-linked Alport syndrome: genes and variants
Explore variant evidence for X-linked Alport syndrome across 1 analyzed protein (COL4A5). Linked ClinVar records include 341 pathogenic or likely pathogenic variants, 121 variants of uncertain significance and 57 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to X-linked Alport syndrome
COL4A5: Collagen alpha-5(IV) chain
It is essential for the alpha3-alpha4-alpha5 type IV collagen network that gives glomerular and cochlear basement membranes their mature mechanical properties. Pathogenic variants cause X-linked Alport syndrome, with progressive kidney disease, hearing loss, and characteristic ocular findings.
341 ClinVar pathogenic / likely pathogenic and 178 uncertain variants in COL4A5 have source records linked to X-linked Alport syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to X-linked Alport syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL4A5 C1632Y | 1632 | Collagen IV NC1 | Pathogenic / likely pathogenic (★★★★) |
| COL4A5 C1632R | 1632 | Collagen IV NC1 | Pathogenic / likely pathogenic (★★★★) |
| COL4A5 R1677Q | 1677 | Collagen IV NC1 | Pathogenic / likely pathogenic (★★★★) |
| COL4A5 G138S | 138 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G171R | 171 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G192R | 192 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G192W | 192 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G230V | 230 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G273E | 273 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G276S | 276 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G325R | 325 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G328S | 328 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G521D | 521 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G594D | 594 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G621S | 621 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G650D | 650 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G743S | 743 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G869R | 869 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G893V | 893 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G1066S | 1066 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G1116V | 1116 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G1143S | 1143 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G1170C | 1170 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G1229S | 1229 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G1264D | 1264 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G54R | 54 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G141D | 141 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G207R | 207 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G213R | 213 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G213E | 213 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G230D | 230 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G289D | 289 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G292R | 292 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G307D | 307 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G307S | 307 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G310E | 310 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G319D | 319 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G328D | 328 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G334D | 334 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G334V | 334 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G380R | 380 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G380S | 380 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G409D | 409 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G409V | 409 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G494R | 494 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G576D | 576 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G603D | 603 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G603V | 603 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G603S | 603 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G621D | 621 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G638S | 638 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G650S | 650 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G778R | 778 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G778S | 778 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G811V | 811 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G834R | 834 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G834V | 834 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G872C | 872 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G899D | 899 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G1018D | 1018 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
Showing 60 of 341.
Uncertain variants prioritized for review in X-linked Alport syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| COL4A5 G893D | 893 | Triple-helical region | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G893V at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.984 |
| COL4A5 G722E | 722 | Triple-helical region | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; G722V at the same position is pathogenic; seen in 9.3e-07 of gnomAD DNA copies; REVEL 0.993 |
| COL4A5 G1170S | 1170 | Triple-helical region | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G1170D at the same position is pathogenic; seen in 2.7e-06 of gnomAD DNA copies; REVEL 0.985 |
| COL4A5 G412E | 412 | Triple-helical region | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G412R at the same position is pathogenic; seen in 9.1e-07 of gnomAD DNA copies; REVEL 0.920 |
| COL4A5 G183D | 183 | Triple-helical region | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G183V at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.970 |
| COL4A5 G1388S | 1388 | Triple-helical region | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; G1388R at the same position is pathogenic; seen in 6.4e-06 of gnomAD DNA copies; REVEL 0.811 |
| COL4A5 G1185D | 1185 | Triple-helical region | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G1185V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| COL4A5 G1439V | 1439 | Triple-helical region | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; G1439D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.92 |
| COL4A5 G409S | 409 | Triple-helical region | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; G409D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.79 |
| COL4A5 G702V | 702 | Triple-helical region | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G702R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.88 |
| COL4A5 G1000V | 1000 | Triple-helical region | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G1000R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.76 |
| COL4A5 C1521S | 1521 | Collagen IV NC1 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; C1521W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| COL4A5 G171S | 171 | Triple-helical region | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G171C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.60 |
| COL4A5 G313V | 313 | Triple-helical region | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; G313C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.87 |
| COL4A5 G120S | 120 | Triple-helical region | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G120D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.81 |
| COL4A5 G224R | 224 | Triple-helical region | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G224V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| COL4A5 G1039D | 1039 | Triple-helical region | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G1039S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.91 |
| COL4A5 G696R | 696 | Triple-helical region | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; G696D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 |
| COL4A5 G609C | 609 | Triple-helical region | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; G609A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.87 |
| COL4A5 G295S | 295 | Triple-helical region | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; G295D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.73 |
| COL4A5 G621V | 621 | Triple-helical region | Uncertain | +6: 3 other pathogenic changes within 3 positions; G621D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.72 |
| COL4A5 G230S | 230 | Triple-helical region | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; G230D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.81 |
| COL4A5 G814E | 814 | Triple-helical region | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; G814R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.93 |
Which prediction tools work for X-linked Alport syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 99 out of 100
- ESM1b (LLR): 99 out of 100
- EVE: 99 out of 100
- MutPred: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 97 out of 100
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 96 out of 100
- phyloP: 94 out of 100
- MetaSVM: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 52 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 52 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Alport syndrome also has ClinVar records linked to COL4A5 variants; they fall in the same places as the X-linked Alport syndrome variants (14 pathogenic / likely pathogenic).
Diseases related to X-linked Alport syndrome
- Alport syndrome, also linked to COL4A5
- Autosomal dominant Alport syndrome, also linked to COL4A5
- Rare genetic deafness, also linked to COL4A5
- Nephrotic syndrome, also linked to COL4A5
- Monogenic hearing loss, also linked to COL4A5
- Steroid-resistant nephrotic syndrome, also linked to COL4A5
- Isolated macular dystrophy, also linked to COL4A5
- Kidney disorder, also linked to COL4A5
Frequently asked questions
Which genes have records linked to X-linked Alport syndrome?
This view contains 1 analyzed proteins: COL4A5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 341 pathogenic or likely pathogenic variants, 121 variants of uncertain significance and 57 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 23 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 635 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center